Transposable hypomethylation is associated with metastatic capacity of primary melanomas

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 12, 2013, Pages 2943-2948

  Ecsedi, Szilvia I ^a,b   Hernandez Vargas, Hector ^c   Lima, Sheila C ^c   Herceg, Zdenko ^c   Adany, Roza ^a,b   Balazs, Margit ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

DNA methylation; Epigenetics; Global hypomethylation; LINE1; Melanoma progression

Indexed keywords

5 METHYLCYTOSINE;

ADULT; ARTICLE; CPG ISLAND; DISEASE COURSE; DISEASE FREE SURVIVAL; DNA METHYLATION; EPIGENETICS; FEMALE; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; GLOBAL HYPOMETHYLATION; HUMAN; KAPLAN MEIER METHOD; LINE1; LONG INTERSPERSED REPEAT; MALE; MELANOMA; MELANOMA PROGRESSION; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PHENOTYPE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SKIN TUMOR; TIME; TRANSPOSON; TREATMENT OUTCOME; YOUNG ADULT;

DNA METHYLATION; EPIGENETICS; GLOBAL HYPOMETHYLATION; LINE1; MELANOMA PROGRESSION;

5-METHYLCYTOSINE; ADULT; CPG ISLANDS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DNA METHYLATION; DNA TRANSPOSABLE ELEMENTS; EPIGENESIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MELANOMA; MIDDLE AGED; PHENOTYPE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84888814836     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. van den Hurk K, Niessen HE, Veeck J, van den Oord JJ, van Steensel MA, Zur Hausen A, van Engeland M and Winnepenninckx VJ. Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune. Biochim Biophys Acta 2012; 1826: 89-102.
2. Heyn H and Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet 2012; 13: 679-692.
3. Balazs M, Ecsedi S, Vizkeleti L, Begany A. Genomics of human malignant melanoma. In: Tanaka Y, editors. Breakthroughs in melanoma research. Rijeka: InTech 2011. pp: 237-263.
4. Wild L and Flanagan JM. Genome-wide hypomethylation in cancer may be a passive consequence of transformation. Biochim Biophys Acta 2010; 1806: 50-57.
5. Sigalotti L, Fratta E, Bidoli E, Covre A, Parisi G, Colizzi F, Coral S, Massarut S, Kirkwood JM and Maio M. Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients. J Transl Med 2011; 9: 78.
6. Sunami E, de Maat M, Vu A, Turner RR and Hoon DS. LINE-1 hypomethylation during primary colon cancer progression. PLoS One 2011; 6: e18884.
7. Tellez CS, Shen L, Estecio MR, Jelinek J, Gershenwald JE and Issa JP. CpG island methylation profiling in human melanoma cell lines. Melanoma Res 2009; 19: 146-155.
8. Haqq C, Nosrati M, Sudilovsky D, Crothers J, Khodabakhsh D, Pulliam BL, Federman S, Miller JR 3rd, Allen RE, Singer MI, Leong SP, Ljung BM, Sagebiel RW and Kashani-Sabet M. The gene expression signatures of melanoma progression. Proc Natl Acad Sci U S A 2005; 102: 6092-6097.
9. Hoshimoto S, Kuo CT, Chong KK, Takeshima TL, Takei Y, Li MW, Huang SK, Sim MS, Morton DL and Hoon DS. AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome. J Invest Dermatol 2012; 132: 1689-1697.
10. Daskalos A, Nikolaidis G, Xinarianos G, Savvari P, Cassidy A, Zakopoulou R, Kotsinas A, Gorgoulis V, Field JK and Liloglou T. Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int J Cancer 2009; 124: 81-87.
11. Lee HS, Kim BH, Cho NY, Yoo EJ, Choi M, Shin SH, Jang JJ, Suh KS, Kim YS and Kang GH. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma. Clin Cancer Res 2009; 15: 812-820.
12. de Maat MF, van de Velde CJ, Benard A, Putter H, Morreau H, van Krieken JH, Meershoek Klein-Kranenbarg E, de Graaf EJ, Tollenaar RA and Hoon DS. Identification of a quantitative MINT locus methylation profile predicting local regional recurrence of rectal cancer. Clin Cancer Res 2010; 16: 2811-2818.
13. Sunami E, Vu AT, Nguyen SL and Hoon DS. Analysis of methylated circulating DNA in cancer patients' blood. Methods Mol Biol 2009; 507: 349-356.
14. Szekvolgyi L, Imre L, Minh DX, Hegedus E, Bacso Z and Szabo G. Flow cytometric and laser scanning microscopic approaches in epigenetics research. Methods Mol Biol 2009; 567: 99-111.
15. Pattamadilok J, Huapai N, Rattanatanyong P, Vasurattana A, Triratanachat S, Tresukosol D and Mutirangura A. LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer. Int J Gynecol Cancer 2008; 18: 711-717.